Searching in Mother Nature for Anti-Cancer Activity: Anti-Proliferative and Pro-Apoptotic Effect Elicited by Green Barley on Leukemia/Lymphoma Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Robles Escajeda, Elisa ^a   Lerma, Dennise ^b   Nyakeriga, Alice M ^c   Ross, Jeremy A ^a   Kirken, Robert A ^a   Aguilera, Renato J ^a   Varela Ramirez, Armando ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b ST MARY'S UNIVERSITY   (United States)

^c Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; FAS LIGAND; GREEN BARLEY EXTRACT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHATIDYLSERINE; PLANT EXTRACT; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BARLEY; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LEUKEMIA CELL LINE; LIPID TRANSPORT; LYMPHOMA CELL LINE; PROTEIN CLEAVAGE; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; HORDEUM; HUMANS; LEUKEMIA; LYMPHOMA; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84883631438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073508     Document Type: Article

References (70)

1. Australian Government,: Department Health and Ageing, Office of the Gene Technology Regulator (2008) The Biology of Hordeum vulgare L.(Barley). 1 ed.
2. Zohary D, Hopf M, (2000) Domestication of plants in the old world: the origin and spread of cultivated plants in West Asia, Europe, and the Nile Valley. xi. Oxford NY: Oxford University Press. 316pp.
3. Madhujith T, Shahidi F, (2007) Antioxidative and antiproliferative properties of selected barley (Hordeum vulgarae L.) cultivars and their potential for inhibition of low-density lipoprotein (LDL) cholesterol oxidation. J Agric Food Chem 55: 5018-5024. doi:10.1021/jf070072a. PubMed: 17542605.
4. Cremer L, Herold A, Avram D, Szegli G, (1996) Inhibitory capacity of some fractions isolated from a green barley extract upon TNF alpha production by the cells of the THP-1 human monocytes line. Roum Arch Microbiol Immunol 55: 285-294. PubMed: 9558963.
5. Osawa T, Katsuzaki H, Hagiwara Y, Hagiwara H, Shibamoto T, (1992) A Novel Antioxidant Isolated from Young Green Barley Leaves. J Agric Food Chem 40: 1135-1138. doi:10.1021/jf00019a009.
6. Cremer L, Herold A, Avram D, Szegli G, (1998) A purified green barley extract with modulatory properties upon TNF alpha and ROS released by human specialised cells isolated from RA patients. Roum Arch Microbiol Immunol 57: 231-242. PubMed: 11845435.
7. Markham KR, Mitchell KA, (2003) The mis-identification of the major antioxidant flavonoids in young barley (Hordeum vulgare) leaves. Zeitschrift fur Naturforschung C, Journal of biosciences 58: 53-56. PubMed: 12622226.
8. Ehrenbergerova J, Brezinova Belcredi N, Kopacek J, Melisova L, Hrstkova P, et al. (2009) Antioxidant enzymes in barley green biomass. Plant foods for human nutrition 64: 122-128.
9. Brezinová Belcredi N, Ehrenbergerová J, Fiedlerová V, Běláková S, Vaculová K, (2010) Antioxidant vitamins in barley green biomass. J Agric Food Chem 58: 11755-11761. doi:10.1021/jf1014389. PubMed: 20973533.
10. Yu YM, Chang WC, Chang CT, Hsieh CL, Tsai CE, (2002) Effects of young barley leaf extract and antioxidative vitamins on LDL oxidation and free radical scavenging activities in type 2 diabetes. Diabetes Metab 28: 107-114. PubMed: 11976562.
11. Benedet JA, Umeda H, Shibamoto T, (2007) Antioxidant activity of flavonoids isolated from young green barley leaves toward biological lipid samples. J Agric Food Chem 55: 5499-5504. doi:10.1021/jf070543t. PubMed: 17539660.
12. Liu RH, (2003) Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78: 517S-520S. PubMed: 12936943.
13. Seeram NP, Adams LS, Hardy ML, Heber D, (2004) Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem 52: 2512-2517. doi:10.1021/jf0352778. PubMed: 15113149.
14. Wang TS, Chen LJ, Wang ZY, Zhang ST, Lin JM, (2011) Purified alkaloid extract of Scutellaria barbata inhibits proliferation of hepatoma HepG-2 cells by inducing apoptosis and cell cycle arrest at G(2)/M phase. African Journal of Pharmacy and Pharmacology 5: 1046-1053.
15. Looi CY, Arya A, Cheah FK, Muharram B, Leong KH, et al. (2013) Induction of Apoptosis in Human Breast Cancer Cells via Caspase Pathway by Vernodalin Isolated from Centratherum anthelminticum (L.) Seeds. PLOS ONE 8: e56643.
16. Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT, et al. (2000) Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. Leukemia 14: 1833-1849. doi:10.1038/sj.leu.2401902. PubMed: 11021759.
17. Igney FH, Krammer PH, (2002) Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277-288. doi:10.1038/nrc776. PubMed: 12001989.
18. Hamblin T, (2006) Natural products and the treatment of leukemia. Leuk Res 30: 649-650. doi:10.1016/j.leukres.2005.10.023. PubMed: 16337269.
19. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, et al. (1985) TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 134: 1623-1630. PubMed: 2578514.
20. Schneider U, Schwenk HU, Bornkamm G, (1977) Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. International journal of cancer Journal international du cancer 19: 621-626. doi:10.1002/ijc.2910190505. PubMed: 68013.
21. Hurwitz R, Hozier J, LeBien T, Minowada J, Gajl-Peczalska K, et al. (1979) Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer J Int Cancer 23: 174-180. doi:10.1002/ijc.2910230206.
22. Klein G, Lindahl T, Jondal M, Leibold W, Menézes J, et al. (1974) Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A 71: 3283-3286. doi:10.1073/pnas.71.8.3283. PubMed: 4369887.
23. Lema C, Varela-Ramirez A, Aguilera RJ, (2011) Differential nuclear staining assay for high-throughput screening to identify cytotoxic compounds. Current Cellular Biochemistry 1: 1-14.
24. Varela-Ramirez A, Costanzo M, Carrasco YP, Pannell KH, Aguilera RJ, (2011) Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells. Cell Biol Toxicol 27: 159-168. doi:10.1007/s10565-010-9178-y. PubMed: 21069563.
25. Shaik N, Martínez A, Augustin I, Giovinazzo H, Varela-Ramírez A, et al. (2009) Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets. Inorg Chem 48: 1577-1587. doi:10.1021/ic801925k. PubMed: 19146434.
26. Liu LF, Duann P, Lin CT, D'Arpa P, Wu J, (1996) Mechanism of action of camptothecin. Ann N Y Acad Sci 803: 44-49. doi:10.1111/j.1749-6632.1996.tb26375.x. PubMed: 8993499.
27. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, et al. (1997) Substrate specificities of caspase family proteases. J Biol Chem 272: 9677-9682. doi:10.1074/jbc.272.15.9677. PubMed: 9092497.
28. Billard C, Kern C, Tang R, Ajchenbaum-Cymbalista F, Kolb JP, (2003) Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia. Leukemia 17: 2435-2443. doi:10.1038/sj.leu.2403139. PubMed: 14523476.
29. Padget K, Pearson AD, Austin CA, (2000) Quantitation of DNA topoisomerase IIalpha and beta in human leukaemia cells by immunoblotting. Leukemia 14: 1997-2005. doi:10.1038/sj.leu.2401928. PubMed: 11069037.
30. Sauerwald TM, Oyler GA, Betenbaugh MJ, (2003) Study of caspase inhibitors for limiting death in mammalian cell culture. Biotechnol Bioeng 81: 329-340. doi:10.1002/bit.10473. PubMed: 12474256.
31. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW, (1983) Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A 80: 5573-5577. doi:10.1073/pnas.80.18.5573. PubMed: 6577444.
32. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, et al. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43. doi:10.1038/376037a0. PubMed: 7596430.
33. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, et al. (1998) Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533-33539. doi:10.1074/jbc.273.50.33533. PubMed: 9837934.
34. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, et al. (1999) Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5: 314-319. doi:10.1038/6535. PubMed: 10086388.
35. Li H, Zhu H, Xu CJ, Yuan J, (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501. doi:10.1016/S0092-8674(00)81590-1. PubMed: 9727492.
36. Troyano A, Sancho P, Fernández C, de Blas E, Bernardi P, et al. (2003) The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells. Cell Death Differ 10: 889-898. doi:10.1038/sj.cdd.4401249. PubMed: 12867996.
37. Fadeel B, Zhivotovsky B, Orrenius S, (1999) All along the watchtower: on the regulation of apoptosis regulators. FASEB J 13: 1647-1657. PubMed: 10506569.
38. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA, (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 31: 1333-1335. doi:10.1177/31.11.6619538. PubMed: 6619538.
39. Riccardi A, Mazzini G, Montecucco C, Cresci R, Traversi E, et al. (1982) Sequential vincristine, arabinosylcytosine and adriamycin in acute leukemia: cytologic and cytokinetic studies. Cytometry 3: 104-109. doi:10.1002/cyto.990030207. PubMed: 7140479.
40. Shin HJ, Baek KH, Jeon AH, Park MT, Lee SJ, et al. (2003) Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 4: 483-497. doi:10.1016/S1535-6108(03)00302-7. PubMed: 14706340.
41. Bar-Nun S, Shneyour Y, Beckmann JS, (1983) G-418, an elongation inhibitor of 80 S ribosomes. Biochim Biophys Acta 741: 123-127. doi:10.1016/0167-4781(83)90018-0. PubMed: 6193810.
42. Gururajan M, Chui R, Karuppannan AK, Ke J, Jennings CD, et al. (2005) c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. Blood 106: 1382-1391. doi:10.1182/blood-2004-10-3819. PubMed: 15890690.
43. Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ, (2004) A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134: 1529-1535. PubMed: 15173424.
44. Lund T, Stokke T, Olsen ØE, Fodstad Ø, (2005) Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis. Br J Cancer 92: 1773-1781. doi:10.1038/sj.bjc.6602537. PubMed: 15827557.
45. Nagata S, (2000) Apoptotic DNA fragmentation. Exp Cell Res 256: 12-18. doi:10.1006/excr.2000.4834. PubMed: 10739646.
46. Wieder T, Prokop A, Bagci B, Essmann F, Bernicke D, et al. (2001) Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia 15: 1735-1742. doi:10.1038/sj.leu.2402284. PubMed: 11681415.
47. Leventis PA, Grinstein S, (2010) The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39: 407-427. doi:10.1146/annurev.biophys.093008.131234. PubMed: 20192774.
48. Dirsch VM, Antlsperger DS, Hentze H, Vollmar AM, (2002) Ajoene, an experimental anti-leukemic drug: mechanism of cell death. Leukemia 16: 74-83. doi:10.1038/sj.leu.2402337. PubMed: 11840266.
49. Quiney C, Billard C, Faussat AM, Salanoubat C, Ensaf A, et al. (2006) Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Leukemia 20: 491-497. doi:10.1038/sj.leu.2404098. PubMed: 16424868.
50. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, et al. (1996) CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 271: 1841-1844. doi:10.1074/jbc.271.4.1841. PubMed: 8567626.
51. Fernandes-Alnemri T, Litwack G, Alnemri ES, (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764. PubMed: 7983002.
52. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, et al. (1996) Human ICE/CED-3 protease nomenclature. Cell 87: 171. doi:10.1016/S0092-8674(00)81334-3. PubMed: 8861900.
53. Bürkle A, Brabeck C, Diefenbach J, Beneke S, (2005) The emerging role of poly(ADP-ribose) polymerase-1 in longevity. Int J Biochem Cell Biol 37: 1043-1053. doi:10.1016/j.biocel.2004.10.006. PubMed: 15743677.
54. Berger NA, (1985) Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 101: 4-15. doi:10.2307/3576299. PubMed: 3155867.
55. Diaz-Hernandez JI, Moncada S, Bolaños JP, Almeida A, (2007) Poly(ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress. Cell Death Differ 14: 1211-1221. doi:10.1038/sj.cdd.4402117. PubMed: 17347665.
56. Loeffler M, Kroemer G, (2000) The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 256: 19-26. doi:10.1006/excr.2000.4833. PubMed: 10739647.
57. Kroemer G, Reed JC, (2000) Mitochondrial control of cell death. Nat Med 6: 513-519. doi:10.1038/74994. PubMed: 10802706.
58. Lahouel M, Amedah S, Zellagui A, Touil A, Rhouati S, et al. (2006) The interaction of new plant flavonoids with rat liver mitochondria: relation between the anti- and pro-oxydant effect and flavonoids concentration. Therapie 61: 347-355. doi:10.2515/therapie:2006025. PubMed: 17124951.
59. Koppikar SJ, Choudhari AS, Suryavanshi SA, Kumari S, Chattopadhyay S, et al. (2010) Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer 10: 210. doi:10.1186/1471-2407-10-210. PubMed: 20482751.
60. Varfolomeev EE, Ashkenazi A, (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell 116: 491-497. doi:10.1016/S0092-8674(04)00166-7. PubMed: 14980217.
61. Tumanov AV, Grivennikov SI, Kruglov AA, Shebzukhov YV, Koroleva EP, et al. (2010) Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs. Blood 116: 3456-3464. doi:10.1182/blood-2009-10-249177. PubMed: 20634375.
62. Micheau O, Tschopp J, (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190. doi:10.1016/S0092-8674(03)00521-X. PubMed: 12887920.
63. Ekert PG, Vaux DL, (1997) Apoptosis and the immune system. Br Med Bull 53: 591-603. doi:10.1093/oxfordjournals.bmb.a011632. PubMed: 9374039.
64. Stennicke HR, Jürgensmeier JM, Shin H, Deveraux Q, Wolf BB, et al. (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273: 27084-27090. doi:10.1074/jbc.273.42.27084. PubMed: 9765224.
65. Ovadje P, Chatterjee S, Griffin C, Tran C, Hamm C, et al. (2011) Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol 133: 86-91. doi:10.1016/j.jep.2010.09.005. PubMed: 20849941.
66. Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, et al. (1992) Profound block in thymocyte development in mice lacking p56lck. Nature 357: 161-164. doi:10.1038/357161a0. PubMed: 1579166.
67. Gonzalez-Garcia A, R-Borlado L, Leonardo E, Merida I, Martinez-A C, et al. (1997) Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J Immunol 158: 4104-4112. PubMed: 9126969.
68. Samraj AK, Stroh C, Fischer U, Schulze-Osthoff K, (2006) The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression. Oncogene 25: 186-197. PubMed: 16116473.
69. Belka C, Marini P, Lepple-Wienhues A, Budach W, Jekle A, et al. (1999) The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene 18: 4983-4992. doi:10.1038/sj.onc.1202878. PubMed: 10490833.
70. Accordi B, Espina V, Giordan M, VanMeter A, Milani G, et al. (2010) Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL. PLOS ONE 5: e13552. doi:10.1371/journal.pone.0013552. PubMed: 21042412.